Video

Utilizing Psychosocial Data to Help Patients with Lung Cancer

Author(s):

There is plenty of scientific data about the physical challenges patients with cancer endure, but more is needed to address psychosocial issues.

Psychosocial challenges for patients with lung cancer are unique to that of other patients with cancer, which is why any research into the psychosocial needs of patients with lung cancer needs to stand on its own. This is what the Cancer Support Community Research and Training Institute is looking to do under their flagship project, the Cancer Experience Registry.

At the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® on Nov. 9, CURE had the chance to sit down with Kelly Clark, MA, manager of research with Cancer Support Community, and discuss how the Cancer Experience Registry allows researchers to look at treating patients with lung cancer from a psychosocial angle.

TRANSCRIPTION

The flagship project at the Cancer Support Community Research and Training Institute is called the Cancer Experience Registry, which is an online survey that documents the cancer experience for both patients and caregivers. Within the cancer experience registry, we have an entire lung initiative that is dedicated to understanding the unique aspects of lung cancer.

In addition to that, we have a report that we have published based on the findings from this lung initiative. And we also go to international research conferences to talk about the data that we collect. In recent years we have talked about issues like stigma for lung cancer patients, psychosocial distress, and quality of life.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content